THE IMPACT OF COVID-19 ON THE INDICATORS OF THE ONCOLOGICAL SERVICE FOR BREAST CANCER IN KAZAKHSTAN
Introduction. According to International Agency for Research on Cancer in 2040, about 3 million new cases of breast cancer (BC) are predicted and about 1 million women are expected to die from this pathology.
The aim of the study to assess the impact of COVID-19 on the indicators of the oncological service for breast cancer in Kazakhstan.
Material and research methods. The main method was a retrospective study using descriptive, analytical methods of biomedical statistics and data of the Ministry of Health of the Republic of Kazakhstan – form No.7 and 35 regarding BC (ICD 10 - C50) for 2011-2020.
Results. For 2011-2020 42,376 new cases of BC and 12,914 deaths from this pathology were registered. The average annual crude incidence rate was 46.4±1.10/0000 (95%CI=44.3-48.5), and increased from 40.8±0.70/0000 (2011) to 51 .3±0.70/0000 in 2019 and then decrease to 44.2±0.70/0000 in 2020 (p<0.001). In dynamics, mortality rates tended to (p<0.001) decrease from 16.1±0.40/0000 (2009) to 11.9±0.40/0000 in 2019 and 11.5± 0.40/0000 in 2020, and the average annual crude mortality rate was 14.2±0.60/0000 (95%CI=13.1-15.3). Indicators of early diagnosis (stage I-II) improved from 73.4% (2011) to 86.9% in 2019, and decreased to 84.2% in 2020. Proportion of patients with stage III decreased (from 20.9% in 2011 to 8.4% in 2019 and to 10.0% in 2020) and stage IV (from 5.6% to 4.2% and 5.0%, respectively), i.e. neglect rates are declining. The indicators of morphological verification improved from 95.7% to 99.4% over the years.
Conclusions. As a result of the analysis, an improvement in the indicators of morphological verification, early diagnosis, a decrease in the neglect and mortality rates were established. The trends in 2011-2019 differed significantly from the period from 2011-2020, which is due to the COVID-19 pandemic on the registration of BC.
Nurbek S. Igissin1,2,3, https://orcid.org/0000-0002-2517-6315
Assem Ya. Toguzbayeva4, https://orcid.org/0000-0003-2937-0278
Aida Zh. Baibusunova1,2, https://orcid.org/0000-0002-4460-0476
Zhansaya B. Telmanova1,2,3, https://orcid.org/0000-0002-2364-6520
Gulnur S. Igissinova4,1, https://orcid.org/0000-0001-6881-2257
Zarina A. Bilyalova1,3, https://orcid.org/0000-0002-0066-235X
Daulet M. Baibosynov1,2, https://orcid.org/0000-0001-9209-9463
Zhanerke R. Azhetova1,2, https://orcid.org/0000-0002-8266-1720
Serikbay T. Orozbaev2, https://orcid.org/0000-0003-3895-0426
Kuanysh T. Kulayev5, https://orcid.org/0000-0002-3886-7238
Yerlan K. Kuandykov5, https://orcid.org/0000-0002-7966-1471
1 Central Asian Institute for Medical Research, Astana, the Republic of Kazakhstan;
2 NCJSC «Astana Medical University», Astana, the Republic of Kazakhstan;
3 Eurasian Institute for Cancer Research, Bishkek, the Kyrgyz Republic;
4 NCJSC «Asfendiyarov Kazakh National Medical University», Almaty, the Republic of Kazakhstan;
5 Khoja Akhmet Yassawi International Kazakh-Turkish University, Shymkent, the Republic of Kazakhstan.
1. Мерков А.М., Поляков Л.Е. Санитарная статистика. М.: Медицина. 1974. 384 с.
2. Пак Д.Д., Рассказова Е.А., Ермощенкова М.В. Рак молочной железы: учебник. М.: Триада-Х, 2010. 162 с.
3. Рассказова Е.А., Рожкова Н.И. Скрининг для ранней диагностики рака молочной железы // Исследования и практика в медицине. 2014. № 1. С. 45-51.
4. Семиглазов В.Ф., Нургазиев К.Ш., Арзуманов A.C. Опухоли молочной железы (лечение и профилактика): учебник. М.: Алма-Ата, 2001. 88 с.
5. Стентон Гланц. Медико-биологическая статистика. М.; 1999. 460 с.
6. Afifi A.M., Saad A.M., Al-Husseini M.J., et al. Causes of death after breast cancer diagnosis: A US population-based analysis // Cancer. 2020. N 126. P. 1559-1567. https://doi.org/10.1002/cncr.32648.
7. Aguiar S., Baiocchi G., Duprat J.P., et al. Value of preoperative testing for SARS-CoV-2 for elective surgeries in a cancer center during the peak of pandemic in Brazil // J Surg Oncol. 2020. N 122. P. 1293–1295.
8. Alagoz O., Lowry K.P., Kurian A.W., et al. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling // Journal of the National Cancer Institute. 2021. N 113(11). P. 1484–1494. https://doi.org/10.1093/jnci/djab097
9. American Cancer Society. Breast Cancer Early Detection and Diagnosis. URL: https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection.html accessed 26 April 2022.
10. Bray F., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA Cancer J Clin. 2008. N 68(6). P. 394–424. https://doi.org/10.3322/caac.21492
11. Cavalcante F.P., Novita G.G., Millen E.C., et al. Management of early breast cancer during the COVID-19 pandemic in Brazil // Breast Cancer Res Treat. 2020. N 184. P. 637–647.
12. Chou C.P., Lin H.S. Delayed Breast Cancer Detection in an Asian Country (Taiwan) with Low COVID-19 Incidence // Cancer Manag. Res. 2021. N 13. P. 5899-5906. https://doi.org/10.2147/CMAR.S314282
13. DeSantis C.E., Fedewa S.A., Goding Sauer A., et al. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women // CA: a cancer journal for clinicians. 2016. N 66(1). P. 31–42. https://doi.org/10.3322/caac.21320
14. de Azambuja E., Brandão M., Wildiers H. et al; Belgian Collaborative Group on COVID-19 Hospital Surveillance and the Belgian Society of Medical Oncology (BSMO). Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis // ESMO Open. 2020. N 5(5). P. e000947. https://doi.org/10.1136/esmoopen-2020-000947
15. Dietz J.R., Moran M.S., Isakoff S.J. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic the COVID-19 pandemic breast cancer consortium // Breast Cancer Res Treat. 2020. doi:10.1007/s10549-020-05644-z.
16. Duffy S.W., Seedat F., Kearins O., et al. The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation // Br. J Cancer. 2022. N 1. P. 1–7. https://doi.org/10.1038/s41416-022-01714-9
17. Eijkelboom A.H., de Munck L., Vrancken Peeters M.J.T.F.D., et al. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study // J Hematol. Oncol. 2021. N 14. P. 64. https://doi.org/10.1186/s13045-021-01073-7
18. Ejaz H., Alsrhani A., Zafar A., et al. COVID-19 and comorbidities: Deleterious impact on infected patients // Journal of infection and public health. 2020. N 13(12). P. 1833–1839. https://doi.org/10.1016/j.jiph.2020.07.014
19. Fedewa S.A., Cotter M.M., Wehling K.A., et al. Changes in breast cancer screening rates among 32 community health centers during the COVID-19 pandemic // Cancer. 2021. N 127 (23). P. 4512–4515. https://doi.org/10.1002/cncr.33859
20. Ferlay J., Colombet M., Soerjomataram I., et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods // Int. J Cancer. 2019. N 144(8). P. 1941–1953. https://doi.org/10.1002/ijc.31937
21. Ferlay J., Ervik M., Lam F., et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. URL: https://gco.iarc.fr/today, 2018, accessed 27 February 2022.
22. Figueroa J.D., Gray E., Pashayan N., et al. Breast Screening Working Group (WG2) of the Covid-19 and Cancer Global Modelling Consortium. The impact of the Covid-19 pandemic on breast cancer early detection and screening // Preventive medicine. 2021. N 151. P. 106585. https://doi.org/10.1016/j.ypmed.2021.106585
23. Freer P. E. The Impact of the COVID-19 Pandemic on Breast Imaging // Radiologic clinics of North America 2021. N 59(1). P. 1–11. https://doi.org/10.1016/j.rcl.2020.09.008
24. Kaufman H.W., Chen Z., Niles J., et al. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic // JAMA Netw Open. 2020. N 3:e2017267.
25. Klabunde C.N., Ballard-Barbash R. Evaluating Population-Based Screening Mammography Programs Internationally // Seminars in breast disease. 2021. N 10(2). P. 102–107. https://doi.org/10.1053/j.sembd.2007.09.007
26. London J.W., Fazio-Eynullayeva E., Palchuk M.B., et al. Effects of the COVID-19 pandemic on cancer-related patient encounters // JCO clinical cancer informatics. 2020. N 4. P. 657–665. https://doi.org/10.1200/CCI.20.00068
27. Maringe C., Spicer J., Morris M., Purushotham A., et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study // The Lancet. Oncology. 2020. N 21(8). P. 1023–1034. https://doi.org/10.1016/S1470-2045(20)30388-0
28. Maroni R., Massat N.J., Parmar D., et al. A case-control study to evaluate the impact of the breast screening programme on mortality in England // British journal of cancer. 2021. N 124(4). P. 736–743. https://doi.org/10.1038/s41416-020-01163-2
29. Moraliyage H., De Silva D., Ranasinghe W., et al. Cancer in Lockdown: Impact of the COVID-19 Pandemic on Patients with Cancer // The oncologist. 2021. N 26(2). P. e342–e344. https://doi.org/10.1002/onco.13604
30. Naidich J.J., Boltyenkov A., Wang J.J., et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on imaging case volumes // Journal of the American College of Radiology. 2020. N 17. P. 865-872. https://doi.org/10.1016/j.jacr.2020.05.004
31. Online Statistical Calculator. https://medstatistic.ru/calculators/averagestudent.html
32. Rosenberg P.S., Barker K.A., Anderson W.F. Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States // Journal of the National Cancer Institute. 2015. N 107(9). https://doi.org/10.1093/jnci/djv159
33. Papautsky E.L., Hamlish T. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic // Breast Cancer Res Treat. 2020. N 184. P.249–254.
34. Siegel R.L., Miller K.D., Fuchs H.E., et al. Cancer statistics, 2021 // CA Cancer J Clin. 2021. N 71. P. 7–33.
35. Sud A., Torr B., Jones M.E. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study // Lancet Oncol. 2020. doi:10.1016/s1470-2045(20)30392-2.
36. The Law of the Republic of Kazakhstan No. 257-IV of March 19, 2010 “About State statistics”. https://adilet.zan.kz/rus/docs/Z100000257_.
37. Wang Q., Berger N.A., Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection // JAMA Oncol. 2021. N 7(2). P. 220-227. https://doi.org/10.1001/jamaoncol.2020.6178
38. WMA Declaration of Helsinki, 2013 – Ethical Principles for Medical Research Involving Human Subjects. https://www.wma.net/.
39. Yin K., Singh P., Drohan B. Breast imaging, breast surgery, and cancer genetics in the age of COVID-19 // Cancer. 2020. doi:0.1002/cncr.33113.
40. Zhang H., Han H., He T., et al. Clinical characteristics and outcomes of COVID-19-infected cancer patients: a systematic review and meta-analysis // J Natl Cancer Inst. 2021. N 113(4). P. 371-380. https://doi.org/10.1093/jnci/djaa168
References:[1-5]
1. Merkov A.M., Polyakov L.E. Sanitarnaya statistika [Sanitary statistics]. M. Meditsina, 1974. 384 p. [in Russian]
2. Pak D.D., Rasskazova E.A., Ermoshchenkova M.V. Rak molochnoi zhelezy: uchebnik. [Breast Cancer: textbook]. Triada-X, 2010, 162 p. [in Russian]
3. Rasskazova E.A., Rozhkova N.I. Skrining dlya rannei diagnostiki raka molochnoi zhelezy [Screening for early diagnosis of breast cancer]. Issledovaniya i praktika v meditsine [Research and practice in medicine]. 2014, 1, pp. 45-51. [in Russian]
4. Semiglazov V.F., Nurgaziev K.Sh., Arzumanov A.C. Opukholi molochnoi zhelezy (lechenie i profilaktika): uchebnik [Breast tumors (treatment and prevention): textbook]. Alma-Ata, 2001, 88 p. [in Russian]
5. Stenton Glants. Mediko-biologicheskaya statistika [Biomedical statistics]. M.; 1999, 460 p. [in Russian]
Number of Views: 70
Category of articles:
COVID-19 - Topical Subject
Bibliography link
Igissin N.S., Toguzbayeva A.Ya., Baibusunova A.Zh., Telmanova Zh.B., Igissinova G.S., Bilyalova Z.A., Baibosynov D.M., Azhetova Zh.R., Orozbaev S.T., Kulayev K.T., Kuandykov Ye.K. The impact of COVID-19 on the indicators of the oncological service for breast cancer in Kazakhstan // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 1, pp. 33-41. doi 10.34689/SH.2023.25.1.004Related publications:
IMMUNOLOGICAL CHANGES IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
EFFICACY OF THE ANTIVIRAL DRUG ENISAMY IODIDE IN SEVERE ADULT ACUTE RESPIRATORY INFECTIONS IN THE COVID-19 ERA
APPLICATION OF ARTIFICIAL INTELLIGENCE IN COMBATING THE COVID-19 PANDEMIC: CURRENT TRENDS AND PROSPECTS. REVIEW
CONSEQUENCES OF THE CORONAVIRUS INFECTION: THE POST-COVID SYNDROME AND MENTAL MANIFESTATIONS. LITERATURE REVIEW
FEATURES OF THE SICKNESS BEHAVIOR OF ARTERIAL HYPERTENSION AND OBESITY DURING THE PANDEMIC OF COVID-19 CORONAVIRUS. REVIEW